-
Signature
-
/s/ Nathan Jeffries, Attorney-in-Fact
-
Issuer symbol
-
BRZE
-
Transactions as of
-
01 Oct 2024
-
Net transactions value
-
-$122,580
-
Form type
-
4
-
Filing time
-
03 Oct 2024, 18:39:59 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BRZE |
Class A Common Stock |
Conversion of derivative security |
|
+4,500 |
+2.1% |
|
220,708 |
01 Oct 2024 |
Direct |
F1, F2 |
| transaction |
BRZE |
Class A Common Stock |
Sale |
$144,540 |
-4,500 |
-2% |
$32.12 |
216,208 |
01 Oct 2024 |
Direct |
F2, F3, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
BRZE |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-4,500 |
-4.7% |
$0.000000 |
91,171 |
01 Oct 2024 |
Class B Common Stock |
4,500 |
$4.88 |
Direct |
F1, F5 |
| transaction |
BRZE |
Class B Common Stock |
Options Exercise |
$21,960 |
+4,500 |
|
$4.88 |
4,500 |
01 Oct 2024 |
Class A Common Stock |
4,500 |
|
Direct |
F1 |
| transaction |
BRZE |
Class B Common Stock |
Conversion of derivative security |
$0 |
-4,500 |
-100% |
$0.000000 |
0 |
01 Oct 2024 |
Class A Common Stock |
4,500 |
|
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: